SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025189
Filing Date
2019-05-10
Accepted
2019-05-10 14:21:24
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv519864_10q.htm 10-Q 489649
2 EXHIBIT 31.1 tv519864_ex31-1.htm EX-31.1 11382
3 EXHIBIT 31.2 tv519864_ex31-2.htm EX-31.2 11227
4 EXHIBIT 32.1 tv519864_ex32-1.htm EX-32.1 5132
5 EXHIBIT 32.2 tv519864_ex32-2.htm EX-32.2 5114
  Complete submission text file 0001144204-19-025189.txt   9254531

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rzlt-20190331.xml EX-101.INS 3369521
7 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20190331.xsd EX-101.SCH 51961
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rzlt-20190331_cal.xml EX-101.CAL 36847
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rzlt-20190331_def.xml EX-101.DEF 258935
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20190331_lab.xml EX-101.LAB 341050
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20190331_pre.xml EX-101.PRE 327476
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 19814250
SIC: 2834 Pharmaceutical Preparations